As shown in Figure 5D, most immune cells were significantly enriched in CRC patients in cluster-2, such as CD8+ T cells, Tregs, resting NK cells, tumor-associated macrophages (TAMs), and resting mast cells. This evidence concerns the gene CD8A and neoplasm.